Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

Grasso, Catherine S, Tang, Yujie, Truffaux, Nathalene, Berlow, Noah E, Liu, Lining, Debily, Marie-Anne, Quist, Michael J, Davis, Lara E +32 more·2015·Nature Medicine
DOI 10.1038/nm.3855

Cited by (686)

Items 601–686 of 686

  1. Additional file 5 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  2. Dual Targeting of Histone Deacetylases and MYC as Potential Treatment Strategy for H3-K27M Pediatric Gliomas
    Danielle Algranati, Roni Oren, Bareket Dassa, Liat Fellus-Alyagor, Alexander N. Plotnikov, Haim Michael Barr, Alon Harmelin, Nir London, Guy Ron, Noa Furth et al. · 2024 · eLife
  3. Reviewer #2 (Public Review): Dual Targeting of Histone Deacetylases and MYC as Potential Treatment Strategy for H3-K27M Pediatric Gliomas
    Danielle Algranati, Roni Oren, Bareket Dassa et al. · 2024 · eLife
  4. Author response: Dual Targeting of Histone Deacetylases and MYC as Potential Treatment Strategy for H3-K27M Pediatric Gliomas
    Danielle Algranati, Roni Oren, Bareket Dassa, Liat Fellus-Alyagor, Alexander N. Plotnikov, Haim Michael Barr, Alon Harmelin, Nir London, Guy Ron, Noa Furth et al. · 2024 · eLife
  5. eLife Assessment: Dual Targeting of Histone Deacetylases and MYC as Potential Treatment Strategy for H3-K27M Pediatric Gliomas
    Yamini Dalal · 2024 · eLife
  6. Dual Targeting of Histone Deacetylases and MYC as Potential Treatment Strategy for H3-K27M Pediatric Gliomas
    Danielle Algranati, Roni Oren, Bareket Dassa, Liat Fellus-Alyagor, Alexander N. Plotnikov, Haim Michael Barr, Alon Harmelin, Nir London, Guy Ron, Noa Furth et al. · 2024 · eLife
  7. Targeted Therapies in Paediatric Brain Tumours
    Julie Bennett, John‐Paul Kilday · 2024 · Springer eBooks
  8. Perspective on the Influence of Biopsy on the Survival of Pediatric Patients with Diffuse Brainstem Gliomas: A Literature Review
    Adria Gabrielle Biondi Soares, Luis Gustavo Biondi Soares, Felipe Salvagni Pereira, Willian Pegoraro Kus, Ludimila Brito Batista, Cleiton Formentin · 2024 · Arquivos Brasileiros de Neurocirurgia Brazilian Neurosurgery
  9. Pediatric-type diffuse high-grade gliomas
    Michelle Monje, Steve E. Braunstein, Mitchel Stuart Berger, Hannes S. Vogel · 2025 · Oxford University Press eBooks
  10. Raphin‐1 mediates the survival and sensitivity to radiation of pediatric‐type diffuse high‐grade glioma via phosphorylated eukaryotic initiation factor 2α‐dependent and ‐independent processes
    Karin Eytan, Moshe Leitner, Amos Toren, Shoshana Paglin, Michal Yalon · 2025 · Molecular Oncology
  11. Patterns of relapse in diffuse intrinsic pontine glioma after convection-enhanced delivery of 124I-omburtamab
    Evan D. Bander, Andrew L A Garton, Luca Pasquini, Anne S. Reiner, Onur Yıldırım, Ahmet Turan Ilıca, Maria A. Donzelli, Sofia S. Haque, Mark M. Souweidane · 2025 · Neuro-Oncology Advances
  12. The Current Landscape of Molecular Pathology for the Diagnosis and Treatment of Pediatric High-Grade Glioma
    Emma Vallee, Alyssa Steller, Ashley Childress, Alayna Koch, Scott I Raskin · 2025 · Journal of Molecular Pathology
  13. CXorf67 in malignancies: Deciphering epigenetic landscapes and clinical implications for precision oncology
    Xinning Yu, Huatao Wu, Yangzheng Lan, Wenjia Chen, Jing Liu · 2025 · Genes & Diseases
  14. Advances in preclinical models for pediatric diffuse intrinsic pontine glioma
    Bieke Van den Ende, Frederik De Smet, Sandra A. Jacobs, An Coosemans, Mattéo Riva · 2025 · International Journal of Cancer
  15. Additional file 1 of Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation
    Anne C. Harttrampf, Maria Eugénia Marques Da Costa, Aline Renoult, Estelle Daudigeos‐Dubus, Birgit Geoerger · 2021 · Figshare
  16. Additional file 4 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  17. Additional file 5 of LncRNA NUTM2A-AS1 silencing inhibits glioma via miR-376a-3p/YAP1 axis
    Yuecheng Zeng, Zhenyu Yang, Yang, Yang, Wang, Peng · 2024 · Figshare
  18. Additional file 6 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  19. Additional file 2 of Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation
    Anne C. Harttrampf, Maria Eugénia Marques Da Costa, Aline Renoult, Estelle Daudigeos‐Dubus, Birgit Geoerger · 2021 · Figshare
  20. Additional file 8 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  21. Additional file 5 of TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist
    Xu, Cheng, Liu, Heng, Christopher J. Pirozzi, Chen, Lee H., Paula K. Greer, Bill H. Diplas, Zhang, Liwei, Matthew S. Waitkus, Yiping He, Hai Yan · 2021 · Figshare
  22. Additional file 3 of TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist
    Xu, Cheng, Liu, Heng, Christopher J. Pirozzi, Chen, Lee H., Paula K. Greer, Bill H. Diplas, Zhang, Liwei, Matthew S. Waitkus, Yiping He, Hai Yan · 2021 · Figshare
  23. Additional file 1 of Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models
    Huiyuan zhang, Du, Yuchen, Qi, Lin, Sophie Xiao, Frank Braun, Kogiso, Mari, Huang, Yulun, Huang, Frank, Aalaa Sanad Abdallah, Milagros Suárez et al. · 2024 · Figshare
  24. Additional file 2 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  25. Additional file 6 of Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation
    Anne C. Harttrampf, Maria Eugénia Marques Da Costa, Aline Renoult, Estelle Daudigeos‐Dubus, Birgit Geoerger · 2021 · Figshare
  26. Additional file 16 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  27. Additional file 10 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  28. Additional file 1 of TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist
    Xu, Cheng, Liu, Heng, Christopher J. Pirozzi, Chen, Lee H., Paula K. Greer, Bill H. Diplas, Zhang, Liwei, Matthew S. Waitkus, Yiping He, Hai Yan · 2021 · Figshare
  29. Additional file 1 of Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways
    Pun, Matthew, Pratt, Drew, Patricia R. Nano, Joshi, Piyush K., Li Jiang, Bernhard Englinger, Rao, Arvind, Cieslik, Marcin, Arul M. Chinnaiyan, Aldape, Kenneth et al. · 2024 · Figshare
  30. Additional file 9 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  31. Additional file 12 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  32. Additional file 4 of Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation
    Anne C. Harttrampf, Maria Eugénia Marques Da Costa, Aline Renoult, Estelle Daudigeos‐Dubus, Birgit Geoerger · 2021 · Figshare
  33. Additional file 4 of TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist
    Xu, Cheng, Liu, Heng, Christopher J. Pirozzi, Chen, Lee H., Paula K. Greer, Bill H. Diplas, Zhang, Liwei, Matthew S. Waitkus, Yiping He, Hai Yan · 2021 · Figshare
  34. Additional file 2 of LncRNA NUTM2A-AS1 silencing inhibits glioma via miR-376a-3p/YAP1 axis
    Yuecheng Zeng, Zhenyu Yang, Yang, Yang, Wang, Peng · 2024 · Figshare
  35. Additional file 1 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  36. Additional file 5 of Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation
    Anne C. Harttrampf, Maria Eugénia Marques Da Costa, Aline Renoult, Estelle Daudigeos‐Dubus, Birgit Geoerger · 2021 · Figshare
  37. Additional file 1 of Laminin-associated integrins mediate Diffuse Intrinsic Pontine Glioma infiltration and therapy response within a neural assembloid model
    Sauradeep Sinha, Michelle S. Huang, Georgios Mikos, Yudhishtar S. Bedi, Luis Soto, Sarah Lensch, Manish Ayushman, Lacramioara Bintu, Nidhi Bhutani, Sarah C. Heilshorn et al. · 2024 · Figshare
  38. Additional file 6 of TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist
    Xu, Cheng, Liu, Heng, Christopher J. Pirozzi, Chen, Lee H., Paula K. Greer, Bill H. Diplas, Zhang, Liwei, Matthew S. Waitkus, Yiping He, Hai Yan · 2021 · Figshare
  39. Additional file 2 of TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist
    Xu, Cheng, Liu, Heng, Christopher J. Pirozzi, Chen, Lee H., Paula K. Greer, Bill H. Diplas, Zhang, Liwei, Matthew S. Waitkus, Yiping He, Hai Yan · 2021 · Figshare
  40. Additional file 4 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Ishi, Yukitomo, Eugene Chekalin, Zeng, Billy, Glicksberg, Benjamin S., Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  41. Additional file 1 of LncRNA NUTM2A-AS1 silencing inhibits glioma via miR-376a-3p/YAP1 axis
    Yuecheng Zeng, Zhenyu Yang, Yang, Yang, Wang, Peng · 2024 · Figshare
  42. Additional file 3 of LncRNA NUTM2A-AS1 silencing inhibits glioma via miR-376a-3p/YAP1 axis
    Yuecheng Zeng, Zhenyu Yang, Yang, Yang, Wang, Peng · 2024 · Figshare
  43. Additional file 3 of Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation
    Anne C. Harttrampf, Maria Eugénia Marques Da Costa, Aline Renoult, Estelle Daudigeos‐Dubus, Birgit Geoerger · 2021 · Figshare
  44. Additional file 7 of TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist
    Xu, Cheng, Liu, Heng, Christopher J. Pirozzi, Chen, Lee H., Paula K. Greer, Bill H. Diplas, Zhang, Liwei, Matthew S. Waitkus, Yiping He, Hai Yan · 2021 · Figshare
  45. Additional file 2 of Laminin-associated integrins mediate Diffuse Intrinsic Pontine Glioma infiltration and therapy response within a neural assembloid model
    Sauradeep Sinha, Michelle S. Huang, Georgios Mikos, Yudhishtar S. Bedi, Luis Soto, Sarah Lensch, Manish Ayushman, Lacramioara Bintu, Nidhi Bhutani, Sarah C. Heilshorn et al. · 2024 · Figshare
  46. Additional file 3 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  47. Additional file 4 of LncRNA NUTM2A-AS1 silencing inhibits glioma via miR-376a-3p/YAP1 axis
    Yuecheng Zeng, Zhenyu Yang, Yang, Yang, Wang, Peng · 2024 · Figshare
  48. Additional file 13 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  49. Additional file 7 of Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation
    Anne C. Harttrampf, Maria Eugénia Marques Da Costa, Aline Renoult, Estelle Daudigeos‐Dubus, Birgit Geoerger · 2021 · Figshare
  50. Additional file 14 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  51. Additional file 15 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  52. Additional file 11 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  53. Additional file 5 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  54. Additional file 7 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  55. Additional file 17 of Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Erik R. Peterson, Sajjakulnukit, Peter, Andrew J. Scott, Caleb Heaslip, Andren, Anthony, Kari Wilder-Romans, Zhou, Weihua, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Figshare
  56. Additional file 1 of Histone H3.3 K27M chromatin functions implicate a network of neurodevelopmental factors including ASCL1 and NEUROD1 in DIPG
    Nichole Lewis, Rachel Herndon Klein, Cailin Kelly, Yee, Jennifer, Paul S. Knoepfler · 2022 · Figshare
  57. KDM6B promotes VEGFA expression and vasculogenic mimicry in glioblastoma cells under hypoxia conditions
    Jie Zhou, Li Li, Yan Zhang, Xiaoli Ma, Xiaoqiang Guo, Aixia Sui · 2026 · Experimental Brain Research
  58. A new hope: Clinical advances in targeted therapies for pediatric diffuse midline glioma
    Joshua Zhu, Maria Tsoli, Jean Borges Bertoldo, Sabine Mueller, David Simon Ziegler · 2025 · Neuro-Oncology Advances
  59. Chemotherapy of brainstem gliomas
    Matthias A. Karajannis, Christina Fong · 2026 · Elsevier eBooks
  60. Molecular Characterization of Pediatric Brainstem Gliomas (DIPG) and Identification of New Therapeutic Targets
    Cláudia C.S. Evangelista · 2018 · theses.fr (ABES)
  61. Développement et caractérisation de modèles vitro et vivo de cancers pédiatriques infiltrant du tronc cérébral (DIPG)
    Alexandre Plessier · 2018
  62. Modélisation in vitro & in vivo de la résistance à la radiothérapie dans les gliomes infiltrants du tronc cérébral (DIPG)
    Coralie Werbrouck · 2020 · theses.fr (ABES)
  63. Nouvelles stratégies thérapeutiques dans le traitement du gliome infiltrant du tronc cérébral
    Guillaume Herrault · 2024
  64. A perfused, parallelized blood brain barrier-tumor platform for compound permeation and efficacy investigations
    Wei Wu Wei, Martin Stano, Bettina Kritzer, Javad Nazarian, Andreas R. Hierlemann, Mario M. Modena · 2026 · Microsystems & Nanoengineering
  65. Development of an Active Chimeric IL13Rα2 ADC for Diffuse Intrinsic Pontine Glioma
    Xiaolei Lian, Victoria Allanson, Samuel V. Rasmussen, Shefali Chauhan, Guak-Kim Tan, Paige Morrow, Kyle Hanson, Emily Lian, Anthony R. Haight, Tyuji Hoshino et al. · 2026 · ImmunoTargets and Therapy
  66. Elongin B orchestrates chromatin and transcriptional programs in H3K27M-mutant diffuse midline glioma
    Alan L. Jiao, Rebecca L. Murdaugh, Adam Fiseha Kebede, Claudia A. Mimoso, Barry M. Zee, Rosemary U. Richard, Kwanha Yu, Caitlin L. Bagnetto, Karen Adelman, Mariella G. Filbin et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Efficacy of chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic pontine glioma: a study based on single-center and SEER data
    Dandan Wang, Xiaohao Liu, Juan Wang, Boya Zhang, Suna Zhai, Jiayao Xu, Long Wang, Yingjuan Zheng, Wei Wei, Yubing Zhou · 2026 · Journal of Neuro-Oncology
  68. MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilities
    Taylor A. Gatesman, Srinidhi Varadharajan, Brenden J. Johnson, Ryan J. Duchatel, Rakesh Pathak, Andrea F. Cruz, Hannah G. Wolfe, Katharine E. Halligan, Lily G. Garton, Marie A. Johnson et al. · 2026 · Cell Reports
  69. Selective histone deacetylase inhibition as a therapeutically relevant strategy in H3K27M-glioma
    Andrew Groves, Orville O. Kirkland, Costanza Lo Cascio, Xiuqi Wang, Caleb Heaslip, Joana Graca Marques, Chen Song, Rebecca Poetschke, Tingjian Wang, Diana H. Chin et al. · 2026 · Neuro-Oncology
  70. Tumor-targeted pan-RAS inhibition as a novel biologic therapy for diffuse midline glioma
    Stefanie-Grace Sbergio, Huazhu Liang, Lucy Chen, Laura Canty, Sheyenne Carette, Sanja Pajovic, Nesrin S Sabha, Arun Kumaran Anguraj Vadivel, Greg L. Beilhartz, Roman A. Melnyk et al. · 2026 · Neuro-Oncology
  71. Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma
    Zili Zhen, Qiang Gao, Yong Ai, Zhihong Qian, Yukui Shang, Yafang Deng, Shuai Chen, Xin Ni, Wei Zhang · 2026 · Molecular Therapy Oncology
  72. Immunogenomic profiling reveals targets for gene therapy in pediatric brain tumors
    Giulia Rovesti, Alejandro Fernandez-Woodbridge, Haidong Yao, Alessia Pancaldi, Chiara Chiavelli, Francesca Gatto, Ulrika Sandvik, Matti Sällberg, Jonas Fuxe, Massimo Dominici et al. · 2026 · Neuro-Oncology Advances
  73. Immunotherapy for Diffuse Midline Glioma: From Preclinical Modeling to Clinical Translation
    Anja Kordowski, Monica M. Pomaville, Jessica Foster, Nicholas Alexander Vitanza · 2026 · Cancers
  74. Exon-skipping antisense oligonucleotides for H3.3K27M-altered diffuse midline glioma therapy
    Lucia Yang, Qian Zhang, John Erby Wilkinson, Shivani Deshpande, Adrian R. Krainer · 2026 · Molecular Therapy — Nucleic Acids
  75. Integrated Proteomic and Metabolomic Analyses of Cerebrospinal Fluid from Pediatric Patients with Diffuse Intrinsic Pontine Glioma
    Yufan Chen, Yafei Wang, Yunkun Wang, Kun Zhang, Chenran Zhang · 2026 · International Journal of Molecular Sciences
  76. Clinical, molecular, and surgical predictors of outcome in non-DIPG pediatric diffuse midline gliomas: A collaborative retrospective analysis
    Sara Iglesias, Victoria Becerra, Pablo Miranda, Trinidad Márquez, Lara Galbarriatu, Pablo Martín Munarriz, Jorge Gimenez, Javier Saceda, Francisca Rius, José Hinojosa · 2026 · Child s Nervous System
  77. A novel combinatorial therapeutic strategy using resveratrol and viral oncolysis for diffuse intrinsic pontine glioma: an in vitro study
    Karthik Gourishetti, Isaiah Davis, Shiv Patel, Karthik Rangavajhula, Christian Jacobsen, Monique Kanitz Ruschel, Darshini Kuruppu, Deepak Bhere · 2026 · 3 Biotech
  78. Integrated Transcriptomic and CRISPR Dependency Analysis Prioritizes a CDK1–AURKB Mitotic Vulnerability Axis in Diffuse Intrinsic Pontine Glioma
    Arnav Rajeev, Soumith Veeragoni, Anish Sundar · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  79. Diffuse intrinsic pontine glioma in the era of H3 K27-altered diffuse midline glioma
    Shepeng Wei, Jing Bao, Xuxu Xu, Zhenjiang Pan · 2026 · Critical Reviews in Oncology/Hematology
  80. Precision medicine for pediatric gliomas
    Lorena Baroni, Éric Bouffet · 2026 · Current Opinion in Oncology
  81. Disruption of lamina-associated genome organization activates neuronal gene programs in H3.3K27M DIPG
    Sajad Hamid Ahanger, Mitchel A. Cole, Eugene Gil, Evan R. Semenza, Joanna J. Phillips, Daniel A. Lim · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Histone-modifying Enzymes as Therapeutic Targets in Glioma
    Briana A. Santo, A. Karim Ahmed, Samuel Emerson · 2026 · Hematology/Oncology Clinics of North America
  83. SETDB1 preferentially silences evolutionarily young retroelements
    Bercin K. Cenik, Simai Wang, Marta Iwanaszko, Benjamin Charles Howard, Irem Aydin, Sarah R. Gold, Vijay Ramani, Ali Shilatifard · 2026 · Proceedings of the National Academy of Sciences
  84. Epigenetic personalized medicine in glioblastoma
    Massimo Romani · 2026 · Handbook of clinical neurology
  85. Case studies and real-world applications
    Bhavesh Dharmani, Yash, Preetpal Singh, Rajwinder Kaur, Thakur Gurjeet Singh, Arun Kumar Singh, Manoj S. Dikkatwar · 2026 · Elsevier eBooks
  86. Layer‐by‐Layer Core–Shell Nanoparticles Encapsulate HDAC Inhibitors and Reduce Diffuse Midline Glioma Neurosphere Proliferation
    Michael H. Marand, Emily Laura Han, Andrew J. Pickering, Nicholas G. Lamson, Nichole Loomis, Elnaz Shaabani, Nicolo L. Benedetto, Paula Therese Hammond, Joelle P. Straehla · 2026 · Nano Select